# A Brain Imaging PET Study of [11C]-Lu AF90103 in Healthy Adult Male Participants

> **NCT05306366** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 8 (actual)

## Conditions studied

- Healthy Young Men

## Interventions

- **DRUG:** [11C]-Lu AF90103

## Key facts

- **NCT ID:** NCT05306366
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-23
- **Primary completion:** 2022-06-07
- **Final completion:** 2022-06-07
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2022-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05306366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05306366, "A Brain Imaging PET Study of [11C]-Lu AF90103 in Healthy Adult Male Participants". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT05306366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*